AJP - Lung Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 290: L1069-L1077, 2006; doi:10.1152/ajplung.00408.2005
1040-0605/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grobe, A. C.
Right arrow Articles by Black, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grobe, A. C.
Right arrow Articles by Black, S. M.

Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase

Albert C. Grobe,1 Sandra M. Wells,1 Eileen Benavidez,1 Peter Oishi,3 Anthony Azakie,4 Jeffrey R. Fineman,3,5 and Stephen M. Black1,2

1Department of Biomedical and Pharmaceutical Sciences and 2International Heart Institute, University of Montana, Missoula, Montana; Departments of 3Pediatrics and 4Surgery, and 5Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California

Submitted 22 September 2005 ; accepted in final form 22 December 2005


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Although oxidative stress is known to contribute to endothelial dysfunction-associated systemic vascular disorders, its role in pulmonary vascular disorders is less clear. Our previous studies, using isolated pulmonary arteries taken from lambs with surgically created heart defect and increased pulmonary blood flow (Shunt), have suggested a role for reactive oxygen species (ROS) in the endothelial dysfunction of pulmonary hypertension, but in vivo data are lacking. Thus the initial objective of this study was to determine whether Shunt lambs had elevated levels of ROS generation and whether this was associated with alterations in antioxidant capacity. Our results indicate that superoxide, but not hydrogen peroxide, levels were significantly elevated in Shunt lambs. In addition, we found that the increase in superoxide generation was not associated with alterations in antioxidant enzyme expression or activity. These data suggested that there is an increase in superoxide generation rather than a decrease in scavenging capacity in the lung. Thus we next examined the expression of various subunits of the NADPH oxidase complex as a potential source of the superoxide production. Results indicated that the expression of Rac1 and p47phox is increased in Shunt lambs. We also found that the NADPH oxidase inhibitor diphenyliodonium (DPI) significantly reduced dihydroethidium (DHE) oxidation in lung sections prepared from Shunt but not Control lambs. As DPI can also inhibit endothelial nitric oxide synthase (eNOS) superoxide generation, we repeated this experiment using a more specific NADPH oxidase inhibitor (apocynin) and an inhibitor of NOS (3-ethylisothiourea). Our results indicated that both inhibitors significantly reduced DHE oxidation in lung sections prepared from Shunt but not Control lambs. To further investigate the mechanism by which eNOS becomes uncoupled in Shunt lambs, we evaluated the levels of dihydrobiopterin (BH2) and tetrahydrobiopterin (BH4) in lung tissues of Shunt and Control lambs. Our data indicated that although BH4 levels were unchanged, BH2 levels were significantly increased. Finally, we demonstrated that the addition of BH2 produced an increase in superoxide generation from purified, recombinant eNOS. In conclusion our data demonstrate that the development of pulmonary hypertension in Shunt lambs is associated with increases in oxidative stress that are not explained by decreases in antioxidant expression or activity. Rather, the observed increase in oxidative stress is due, at least in part, to increased expression and activity of the NADPH oxidase complex and uncoupled eNOS due to elevated levels of BH2.

oxidative stress; pulmonary hypertension; antioxidants

CHILDREN WITH CONGENITAL HEART DISEASE and increased pulmonary blood flow suffer significant morbidity and mortality due to pulmonary vascular remodeling and its resultant increase in pulmonary arterial pressure and/or resistance. Indeed, pulmonary morphometric analysis of the lungs of these patients shows altered pulmonary vascular growth and remodeling, which correlates with the hemodynamic state (32). In addition, these children have evidence of endothelial dysfunction as indicated by impaired endothelium-dependent relaxation in early disease and decrease endothelial nitric oxide synthase (eNOS) gene expression in late disease (9, 12). We have established a lamb model that mimics a congenital heart defect with increased pulmonary blood flow using in utero placement of an aorta-to-pulmonary artery vascular graft (33). This model is associated with increased pulmonary blood flow and pressure. At 4 wk of age, these Shunt lambs have clinical and pathologic sequelae similar to children with congenital heart defects associated with increased pulmonary blood flow and pulmonary hypertension, including a selective impairment of endothelium-dependent pulmonary vasodilation.

Using isolated pulmonary arteries taken from shunt lambs, we have previously found that the removal of superoxide enhanced endothelium-dependent relaxations (38). Thus the endothelial dysfunction associated with pulmonary hypertension may be due, in part, to excessive superoxide production. However, the mechanisms by which this increased oxidative stress are produced remains unresolved. The primary source of reactive oxygen species in vascular cells is superoxide-generating NADPH oxidase (39, 42, 43, 45, 46), whereas eNOS can also produce superoxide when uncoupled (18, 20). This occurs when the consumption of NADPH is uncoupled from nitric oxide (NO) synthesis resulting in the production of superoxide anions and hydrogen peroxide (H2O2). This uncoupling can occur in conditions in which there is reduced availability of the cofactor, tetrahydrobiopterin (BH4) or the substrate, L-arginine. Under normal conditions, eNOS produces NO in the vasculature that can rapidly combine with superoxide to produce the oxidant peroxynitrite, which can oxidize a variety of biological molecules (18, 35). H2O2, produced via the dismutation of superoxide, can also serve as a signaling molecule within the vasculature. Antioxidant enzyme systems play a role in the regulation of oxidant levels in the vasculature and could potentially play a role in the development of diseases (including hypertension), and dysregulation of these systems could lead to imbalances in the normal signaling, resulting in pathological manifestations (45). There are several antioxidant systems, including superoxide dismutases (SOD) and catalase, which regulate the presence of oxidant species in vivo. There are two SOD in cells, Cu/ZnSOD (SODI) in the cytoplasm and MnSOD (SODII) in the mitochondria, whereas extracellular SOD (SODIII) is present in the extracellular spaces. These enzymes catalyze the rapid conversion of superoxide into H2O2 and oxygen, whereas H2O2 is converted within the cell to oxygen and water by the action of catalase (45). These systems serve to keep oxidant levels low, thereby reducing oxidant stress. Thus the purpose of this study was to explore the mechanisms underlying the increase in oxidative stress in lambs with pulmonary hypertension secondary to increased pulmonary blood flow (33).


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Surgical preparations and care. Twelve mixed-breed Western pregnant ewes (137–141 days gestation, term = 145 days) were operated on under sterile conditions with the use of local anesthesia (2% lidocaine hydrochloride) and inhalational anesthesia (1–3% isoflurane). A midline incision was made in the ventral abdomen, and the pregnant horn of the uterus was exposed. Through a small uterine incision, the left fetal forelimb and chest were exposed, and a left lateral thoracotomy was performed in the third intercostal space. Additional fetal anesthesia consisted of local anesthesia with 1% lidocaine hydrochloride and ketamine hydrochloride (20 mg im). With the use of side-biting vascular clamps, an 8.0-mm Gore-tex vascular graft (~2 mm length; W. L. Gore and Associates, Milpitas, CA) was anastomosed between the ascending aorta and main pulmonary artery with 7.0 prolene (Ethicon, Somerville, NJ) by a continuous suture technique. The thoracotomy incision was then closed in layers. This procedure was previously described in detail (28).

Four weeks after spontaneous delivery, the lambs were fasted for 24 h, with free access to water. The lambs were then anesthetized with ketamine hydrochloride (15 mg/kg im). With the lambs under additional local anesthesia with 1% lidocaine hydrochloride, polyurethane catheters were placed in an artery and vein of a hind leg. These catheters were advanced to the descending aorta and the inferior vena cava, respectively. The lambs were then anesthetized with ketamine hydrochloride (~0.3 mg·kg–1·min–1), diazepam (0.002 mg·kg–1· min–1), and fentanyl citrate (1.0 µg·kg–1·h–1), intubated with a 7.0-mm outer-diameter cuffed endotracheal tube, and mechanically ventilated with a Healthdyne pediatric time-cycled, pressure-limited ventilator. Utilizing strict aseptic technique, we then performed a midsternotomy incision. The lambs were maintained normothermic (39°C) with a heating blanket. A side-biting vascular clamp was utilized to isolate peripheral lung tissue from randomly selected lobes, and the incisions were cauterized. Approximately 300 mg of peripheral lung were obtained for each biopsy; four biopsies were obtained.

At the end of the protocol, all lambs were killed with a lethal injection of pentobarbital sodium followed by bilateral thoracotomy as described in the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. All protocols and procedures were approved by the Committee on Animal Research of the University of California, San Francisco (UCSF).

In situ detection of superoxide and H2O2. Snap-frozen lung tissue samples (stored at –80°C) were embedded in Tissue-Tek OCT compound (Sakura Finetek USA, Torrance, CA), cryosectioned at 20 µm, collected onto Superfrost plus slides (VWR Scientific, West Chester, PA), allowed to air-dry at room temperature, and stored at –80°C until needed. Slides were placed into PBS for 30 min at room temperature and then stained with dihydroethidium (DHE, 10 µM) or dichlorodihydrofluorescein diacetate (H2DCF-DA) (100 µM) in PBS for 30 min in a moist chamber in the dark. The slides were rinsed extensively with PBS, coverslipped, imaged with an Olympus IX51 inverted microscope, and analyzed with Image-Pro Plus software (Media Cybernetics, Silver Spring, MD). Values were averaged from multiple vessels captured within each section.

For inhibitor studies, slides were incubated with 1 µM apocynin, 10 µM diphenyliodonium (DPI), or 100 µM 3-ethylisothiourea (3-ETU) for 30 min before being stained with DHE as described above. All inhibitors were obtained from EMD Biosciences (La Jolla, CA).

Slides were also pretreated with polyethylene glycol (PEG)-SOD (50 U/slide), PEG-catalase (250 U/slide) or vehicle before being stained with DHE or DCFDA as described above. PEG-SOD and PEG-catalase were obtained from Sigma Chemical (St. Louis, MO).

Western blotting. Lung protein extracts were prepared by homogenizing peripheral lung tissues in Triton lysis buffer (50 mM Tris·HCl, pH 7.6, 0.5% Triton X-100, 20% glycerol) containing a protease inhibitor cocktail. Extracts were then clarified by centrifugation (15,000 g 10 min at 4°C). Supernatant fractions were then assayed for protein concentration with the Bradford reagent (Bio-Rad, Richmond, CA) and used for Western blot analysis. Western blot analysis was performed as previously described. Membranes were probed with antibodies to SODI (17), SODII (Anti-MnSOD; Upstate, Lake Placid, NY), catalase (Research Diagnostics, Flanders, NJ), p47phox (generated to amino acids 111–127 CPHLLNFFKVRPDDLKL that represent a conserved region present in p47phox from human, rat, mouse, and cow), Rac1, p67phox, and eNOS (BD Transduction Labs, San Diego, CA), and GTP cyclohydrolase. Reactive bands were visualized using the SuperSignal West Femto Maximum Sensitivity Substrate Kit (Pierce, Rockford, IL) and Kodak 440CF image station (Kodak, New Haven, CT). The intensity of the reactive bands was quantified using the Kodak 1D software.

SOD activity assay. Frozen (–80°C) lung tissue was weighed, 5x the weight of 10 mM EDTA was added, and the tissue was minced and sonicated with 3x 10-s pulses at 40% power (High Intensity Ultrasonic Processor, Autotune series; A. Daigger, Vernon Hills, IL). The samples were centrifuged at 20,000 g, 4°C for 15 min, the supernatant was collected, and aliquots were frozen at –80°C until needed. Tissue SOD activity was determined by a modification of the method of Elstner and Heupel (11) using bovine liver SOD (Sigma Chemical) to generate the standards.

Catalase assay. Catalase activity was quantified by a modification of the method of Aebi (2) in 50 mM potassium phosphate buffer, pH 7.0. For each sample 40 µg of protein were added to buffer, 3% H2O2 (~10 mM) was added, and the consumption followed at 240 nm for 60 s using the Shimadzu UV-1700 Pharmaspec and UV Probe software (Shimadzu, Columbia, MD). The change in absorbance was used to calculate catalase-specific activity using the extinction coefficient of 43.6 mM–1 cm–1.

High-performance liquid chromatography determination of tissue BH4 and dihydrobiopterin. Dihydrobiopterin (BH2) and BH4 content were measured by high-performance liquid chromatography (HPLC) with fluorescent detection after differential iodine oxidation as described by Milstien et al. (28) with minor modifications. In brief, ~200 µg of lung tissue were sonicated in 500 µl of 50 mM Tris buffer (pH 7.4) with 1 mM DTT and 1 mM EDTA and centrifuged at 20,000 g for 15 min at 4°C. Protein content of the supernatants was determined by the Bio-Rad DC Protein Assay (Bio-Rad Laboratories, Hercules, CA). For the acidic oxidation, 100 µl of supernatant were added to 50 µl of 1 M H3PO4 containing 5 µl of 1% I2 in 2% KI (wt/vol). After 60 min at room temperature, excess I2 was reduced by addition of 1% ascorbic acid until the solution was colorless. For the basic oxidation, 100 µl of supernatant were added to 10 µl of 1 M NaOH containing 50 µl of 1% I2 in 2% KI (wt/vol). After 60 min at room temperature, 40 µl of 1 M H3PO4 were added, and the sample was treated as described above for the acidic oxidation. All samples were centrifuged at 20,000 g for 2 min, and 25 µl of each sample were used for HPLC analysis.

Detection of BH2 and BH4 was performed using an Amersham Biosciences AKTA purifier system (GE Healthcare, Piscataway, NJ) with a Spherisorb 5 µM ODS1 reverse phase column (4.6 x 250 mm; Waters, Milford, MA), equipped with a Jasco FP-2020 fluorescence detector (Jasco, Tokyo, Japan). BH2 and BH4 levels were quantified by fluorescence detection at 450 nm (emission) and 350 nm (excitation) using an isocratic elution in 5% methanol/95% H2O over 20 min at a flow rate of 0.8 ml/min. Retention time for reduced pterins was ~14 min as confirmed by a standard. We calculated total BH4 level by subtracting the amount of reduced pterins present following oxidation in base by the amount of reduced pterins present following oxidation in acid. Total BH2 was determined as the amount of reduced pterins present following oxidation in base.

Purification of recombinant human eNOS. The poly-His-pCWeNOS vector (a gift from Paul Ortiz de Montellano, UCSF) was transformed in to the protease-deficient Escherichia coli strain BL21 (DE3) pLysS (Novagen). Cells were grown in Luria broth with 1% glycerol containing 200 µg/ml ampicillin and 40 µg/ml chloramphenicol. Cultures were grown at 28°C until an optical density at 600 nm (OD600) of 0.8 was reached. Approximately 1 h before that, heme precursor {delta}-aminolevulinic acid (0.5 mM final concentration) was added. Cells were then induced by addition of isopropyl-beta-D-thiogalactoside (0.8 mM final concentration); 0.5 mM ATP and 3 µM riboflavin were also added, and the cells were then grown at 22°C for a further 48 h in the dark. Cells were then harvested by centrifugation (15 min at 4,000 g at 4°C) and resuspended in lysis buffer [40 mM N-(2-hydroxyethyl)piperazine-N-(3-propane sulfonic acid) (EPPS), pH 7.6, containing 1 mg/ml lysozyme, 150 mM NaCl, 0.5 mM L-arginine, 4 µM BH4, 2 µM flavin adenine dinucleotide (FAD), 10% glycerol] and protease inhibitor cocktail (Sigma). The bacterial suspension was incubated with mild shaking at 4°C for 30 min to ensure complete cell lysis. Cells were broken by sonication with three 25-s pulses followed by three cycles of freezing and thawing. Cell debris was removed by centrifugation at 30,000 g for 30 min at 4°C . The supernatant was then applied to a Ni-NTA His-Bind Superflow (Novagen) column preequilibrated with buffer A (40 mM EPPS, pH 7.6, containing 150 mM NaCl, 10% glycerol, and 0.5 mM L-arginine). The column was washed with five bed volumes of buffer A followed by buffer B (buffer A with 25 mM imidazole). The bound protein was then eluted with buffer C (buffer A + 200 mM imidazole). The heme-containing fractions were pooled and concentrated using centriprep-100 YM-10 (Millipore). The concentrated proteins were dialyzed against three changes of buffer A containing 4 µM BH4 and 1 mM DTT. The protein were further purified by using a 2'5'-ADP-Sepharose column equilibrated with 40 mM Tris buffer pH 7.6, containing 1 mM L-arginine, 3 mM DTT, 4 µM BH4, 4 µM FAD, 10% glycerol, and 150 mM NaCl (buffer D) and washed with buffer D containing 400 mM NaCl to prevent nonspecific binding. eNOS was then eluted with buffer E (buffer D with 5 mM 2' adenine monophosphate). The heme-containing fractions were pooled; concentrated; dialyzed at 4°C against buffer D containing 1 mM DTT, 4 µM BH4, 4 µM FAD, and 10% glycerol; and stored at –80°C until used. The DTT, BH4, and FAD were removed by repeated buffer exchange using Centricon centrifugal filters before use.

Electron spin resonance spectroscopy and spin trapping. Spin trapping measurements of oxygen radical generation were performed using a MiniScope MS200 instrument (Magnettech, Berlin, Germany). The reaction mixture consisted of 50 mM HEPES, pH 7.4, containing 1 mM NADPH, 1 mM Ca2+, 1 mM DTPA, 10 µg/ml calmodulin, and 4 µM BH4 in 50 µl. Purified eNOS (2 µg) and BH2 (250 nM–100 µM) were added to the reaction with 10 mM 5-diethoxyphosphoryl-5-methyl-1-pyrroline-n-oxide (DEPMPO) as the spin trap. The samples (35 µl) were loaded into a 50-µl capillary tube, and spectra were obtained after 20 min with the following parameters: microwave power of 80 mW, modulation amplitude of 1,000 mG, and modulation frequency of 100 kHz. Quantitation of the amplitude of free radical signals was performed using ANALYSIS version 2.02 software (Magnettech).

Statistical analysis. Statistical calculations were performed using the software GraphPad Prism version 4.01 for Windows (GraphPad Software, San Diego CA; www.graphpad.com). Means ± SE were calculated for all samples, and significance was determined either by the unpaired t-test (for 2 groups) or ANOVA with Dunnett's post hoc test (for ≥3 groups). A value of P < 0.05 was considered significant (29).


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Superoxide but not H2O2 levels are increased in Shunt compared with control lambs. Initially we used the fluorescent dyes DHE and H2DCF-DA to determine whether superoxide and H2O2 were altered in pulmonary vessels of Shunt compared with Control lambs at 4 wk of age (n = 6 for each). The results obtained indicate that DHE oxidation was 2.5-fold higher in the pulmonary arteries isolated from Shunt lambs relative to controls (Fig. 1, A and B, P < 0.05), whereas H2DCF-DA fluorescence was unchanged (Fig. 1, C and D; P > 0.05). Pretreatment of the tissue sections with either PEG-SOD (Fig. 1B) or PEG-catalase (Fig. 1D) significantly reduced the quantifiable DHE or H2DCF-DA fluorescence in respective tissue sections.


Figure 1
View larger version (37K):
[in this window]
[in a new window]
  		Fig. 1. In situ detection of superoxide and hydrogen peroxide in pulmonary vessels of Shunt and Control lambs. A: unfixed frozen sections (5 µm) of peripheral lung prepared from Control and Shunt lambs were incubated with dihydroethidium (DHE) alone (10 µM) or after pretreatment with polyethylene glycol (PEG)-SOD (100 units) and visualized by fluorescent microscopy. Under identical imaging conditions, DHE oxidation was significantly increased in the pulmonary vessels of the Shunt compared with Control lambs. In sections prepared from both Shunt and Control the pretreatment with PEG-SOD reduces ethidium fluorescence. B: average SOD-inhibited ethidium fluorescence intensities from images in A were determined. Values are means ± SE from 6 Control and 6 Shunt lambs. *P < 0.05 vs. control. C: unfixed frozen sections (5 µm) of peripheral lung prepared from Control and Shunt lambs were incubated with either dichlorodihydrofluorescein diacetate (H2DCF-DA) alone (100 µmol/l) or after pretreatment with PEG-catalase (100 units) and visualized by fluorescent microscopy. Under identical imaging conditions there were no changes in H2DCF-DA fluorescence in the pulmonary vessels of the Shunt compared with Control lambs. In sections prepared from both Shunt and Control, pretreatment with PEG-catalase reduces H2DCF-DA fluorescence. D: average catalase-inhibited H2DCF-DA fluorescence intensities from images in C were determined. Values are means ± SE from 6 Control and 6 Shunt lambs. There were no significant changes in H2DCF-DA fluorescence.

 
Catalase, SODI, and SODII expression is unchanged in Control and Shunt lambs. Changes in lung antioxidant systems could produce the observed differences in superoxide (determined by DHE) or H2O2 (determined by DCFDA), and Western blot analysis was used to evaluate the expression of catalase, SODI, and SODII. The data obtained indicate that there were no differences in expression of catalase (Control = 264,693 ± 30,256; Shunt = 248,938 ± 29,481), SODI (Control = 601,146 ± 86,351; Shunt = 910,558 ± 150,825) or SODII (Control = 166,299 ± 20,547; Shunt = 232,149 ± 29,606) between Control and Shunt lambs (all P > 0.05).

SOD and catalase activities are unchanged between Control and Shunt lambs. Because the levels of catalase, SODI, and SODII were unchanged, we next evaluated whether the activity of these proteins was altered in Shunt compared with Control lambs. Again, we observed no differences in either catalase (Control = 5.23 x 10–4 ± 0.57 x 10–4 IU/40 µg protein; Shunt = 6.3 x 10–4 ± 0.98 x 10–4 IU/40 µg protein, P > 0.05) or total SOD activity (Control = 6.1 ± 0.54 U/mg protein; Shunt = 7.63 ± 0.78 U/mg protein, P > 0.05) between Control and Shunt lambs.

NADPH oxidase subunit expression is increased in Shunt compared with Control lambs. As the increase in superoxide levels in Shunt lambs was not accounted for by decreases in antioxidant proteins, we next evaluated other potential sources of superoxide. The primary source of superoxide in the vasculature is believed to be NADPH oxidase a multisubunit protein that requires the action of a number of subunits to become functional. Our previous data have suggested that Rac1, p47phox, and p67phox are important in the generation of superoxide in the pulmonary vasculature, and we used Western blot analysis to determine whether the expression of these subunits was altered in Shunt compared with Control lambs. Our results indicate that the expression of Rac1 (Fig. 2, A and B; P < 0.05) and p47phox (Fig. 2, C and D; P < 0.05) were elevated in Shunt lambs, whereas p67phox expression was unchanged (Fig. 2, E and F; P > 0.05).


Figure 2
View larger version (27K):
[in this window]
[in a new window]
  		Fig. 2. Western blot analysis for NADPH oxidase subunit expression in peripheral lung tissue from Control and Shunt lambs. A: protein extracts (25 µg) prepared from peripheral lung were separated on a 4–20% Tris-SDS-HEPES gel, electrophoretically transferred to Hybond membranes, and analyzed using a specific antiserum raised against Rac1 protein. Shown is a representative blot. B: there was a significant increase in densitometric values for Rac1 protein in peripheral lung tissue from 6 Control and 6 Shunt lambs. Values are means ± SE. *P < 0.05 vs. control. C: protein extracts (25 µg) prepared from peripheral lung were separated on a 4–20% Tris-SDS-HEPES gel, electrophoretically transferred to Hybond membranes, and analyzed using a specific antiserum raised against p47phox protein. Shown is a representative blot. D: there was a significant increase in densitometric values for p47phox protein in peripheral lung tissue from 6 Control and 6 Shunt lambs. Values are means ± SE. *P < 0.05 vs. control. E: protein extracts (25 µg) prepared from peripheral lung tissue were separated on a 4–20% Tris-SDS-HEPES gel, electrophoretically transferred to Hybond membranes, and analyzed using a specific antiserum raised against p67phox protein. Shown is a representative blot. F: there are no significant differences in densitometric values for p67phox protein in peripheral lung tissue from 6 Control and 6 Shunt lambs. Values are means ± SE.

 
NADPH oxidase and eNOS are significant sources of the increased superoxide observed in Shunt compared with Control lambs. We utilized pharmacologic inhibitors of NADPH oxidase to further confirm the role played by NADPH oxidase activity in the increased superoxide observed in Shunt lambs. Slides of cryosectioned lung tissues were pretreated with either PBS or inhibitors of NADPH oxidase (apocynin and DPI) before exposure to DHE. When we evaluated DHE oxidation of multiple vessels within the lungs of Control lambs, no significant differences were observed between inhibitor-treated and untreated sections (Fig. 3A). However, in sections prepared from Shunt lambs, DHE oxidation was decreased by 53% for apocynin (P < 0.01) and ~71% for DPI (P < 0.01) (Fig. 3B). As DPI can also inhibit eNOS activity, we also examined the potential for an uncoupled eNOS to be playing a role in the increased superoxide generation observed in Shunt compared with Control lambs. To accomplish this, we pretreated slides of cryosectioned lung tissues with either PBS or the NOS inhibitor 3-ETU. Again 3-ETU had no effect on DHE oxidation in sections prepared from Control lambs (Fig. 3A). However, in sections prepared from Shunt lambs, DHE oxidation was decreased by ~54% by pretreatment with 3-ETU (P < 0.01) (Fig. 3B). These data suggest that both NADPH oxidase and eNOS are responsible, at least in part, for the increased superoxide generation observed in the lungs of Shunt compared with Control lambs.


Figure 3
View larger version (21K):
[in this window]
[in a new window]
  		Fig. 3. Both NADPH oxidase and endothelial nitric oxide synthase (eNOS) contribute to the increased superoxide generation in Shunt lambs. A: unfixed frozen sections (5 µm) of peripheral lung prepared from Control lambs were incubated pretreated with inhibitors of NADPH oxidase (apocynin), eNOS [e-ethylisothiourea (3-ETU)], or both [diphenyliodonium (DPI)]; then the effects on ethidium fluorescence were visualized by fluorescent microscopy. Relative changes in DHE oxidation relative to untreated (UTD) sections were then determined. None of the inhibitors significantly altered DHE oxidation. Values are means ± SE from 6 Control and 6 Shunt lambs. B: unfixed frozen sections (5 µm) of peripheral lung prepared from Shunt lambs were incubated pretreated with inhibitors of NADPH oxidase (apocynin), eNOS (3-ETU), or both (DPI); then the effects on DHE oxidation were visualized by fluorescent microscopy. Relative changes in ethidium fluorescence relative to UTD sections were then determined. DHE oxidation was significantly decreased by pretreatment with apocynin, ETU, and DPI in the pulmonary vessels of the Shunt lambs. Values are means ± SE from 6 Control and 6 Shunt lambs. *P < 0.05 vs. untreated.

 
One potential mechanism by which eNOS becomes a significant source of superoxide is by uncoupling under conditions where BH4 levels are decreased. Thus we next evaluated the potential role of altered biopterin metabolism in Shunt lambs to evaluate its role in eNOS uncoupling. However, when lung tissue levels of BH4 were quantified by HPLC, levels were found to be unchanged in Shunt compared with Control lambs (Fig. 4A). As the rate-limiting step in BH4 biosynthesis is controlled by GTP cyclohydrolase I, we also evaluated the expression of this protein by Western blot analysis. Confirming the HPLC analysis, we found no significant differences between Shunt and Control lambs (Control = 42,556 ± 11,015; Shunt = 38,789 ± 8,932; P > 0.05). However, we did find that the tissue levels of BH2 (an oxidized form of BH4) were significantly elevated in the lungs of Shunt compared with Control lambs (Fig. 4B, P < 0.05).


Figure 4
View larger version (16K):
[in this window]
[in a new window]
  		Fig. 4. Determination of dihydro (BH2)- and tetrahydrobiopterin (BH4) levels in peripheral lung tissue from Control and Shunt Lambs. The levels of BH4 (A) and BH2 (B) were determined in peripheral lung homogenates by HPLC. There were no significant differences in BH4 levels in peripheral lung tissue from Control and Shunt lambs (A). However, BH2 levels were found to be significantly higher in peripheral lung tissue from Shunt compared with Control and lambs. Values are means ± SE from 6 Control and 6 Shunt lambs. *P < 0.05 vs. Control.

 
Elevated BH2 levels lead to an uncoupling of eNOS. Finally, we evaluated whether our observed increases in BH2 (an oxidized form of BH4) could uncouple eNOS. Using ESR, we found that the addition of BH2 dose dependently uncoupled eNOS and led to an increase in superoxide generation by purified recombinant human eNOS (Fig. 5). Furthermore, this uncoupling could be achieved using the ratio of BH2/BH4 (1:7) we determined in vivo.


Figure 5
View larger version (11K):
[in this window]
[in a new window]
  		Fig. 5. BH2 stimulates eNOS superoxide generation. Purified human eNOS (2 µg) containing BH4 (4 µM), NADPH (1 mM), Ca2+ (1 mM), or calmodulin (10 µg/ml) was incubated with increasing concentrations of BH2 (250 nM–100 µM), and the superoxide generated was trapped with 5-diethoxyphosphoryl-5-methyl-1-pyrroline-n-oxide (10 mM). Increasing concentrations of BH2 led to a significant increased in eNOS-derived superoxide. Values are means ± SE from 6 determinations for each BH2/BH4 ratio. *P < 0.05 vs. no BH2.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
An increasing number of studies implicate oxidative stress in the development of endothelial dysfunction and the pathogenesis of cardiovascular disease (8, 15). Furthermore, an increasing body of evidence suggests that endothelial injury and the resulting alterations in the balance of vasoactive substances play a significant role in the development of pulmonary hypertension (9, 10, 31). Support for this hypothesis is strengthened by observations that endothelial injury precedes the vascular remodeling seen in several animal models of pulmonary hypertension (1, 26). In humans, endothelial dysfunction, demonstrated by histological abnormalities of the endothelium, impairment of endothelium-dependent pulmonary vasodilation, as well as increased plasma endothelin-1 concentrations, has been described in children with congenital heart defects and pulmonary hypertension before the development of significant vascular remodeling (9, 31, 48). There is also increasing evidence that alterations in the production and/or ability to scavenge reactive oxygen species (ROS) participate in the endothelial dysfunction associated with pulmonary hypertension. We have previously shown that both superoxide (6) and H2O2 (47) are increased in an ovine ductal ligation model of persistent pulmonary hypertension of the newborn (PPHN). In addition, our previous data indicated that superoxide scavenging via SOD increased NO-mediated signaling in pulmonary vessels isolated from Shunt lambs, suggesting that the underlying endothelial dysfunction in these lambs is also associated with increased oxidative stress (38). In this study, our initial data confirmed an increase in superoxide generation although interestingly not H2O2. There are two mechanisms by which the increase in superoxide levels could occur in the Shunt lambs: either by decreased scavenging or by increased generation. To determine whether the observed differences in oxidant levels in Shunt lambs could be explained by alterations in these enzyme systems, we initially evaluated the levels of SOD and catalase expression and activity as the major antioxidant systems in shunt lambs responsible for superoxide and H2O2 removal. However, when we evaluated SODI and SODII expression as well as SOD activity, no significant differences were seen between Shunt and Control lambs. This indicates that the increased superoxide seen in the Shunt lambs is not explained by decreases in SOD protein expression or activity. A similar increase in superoxide levels independent of changes in SOD activity has been previously described in a rodent model of hypertension by Landmesser et al. (20).

Because the increases in superoxide levels observed in Shunt lambs could not be explained by alterations in SOD expression or activity, we next investigated the involvement of superoxide-generating enzymes. Sources of superoxide within the vasculature include lipoxygenase, cyclooxygenase, xanthine oxidase, NOS, and NADPH oxidase (24); however, it is generally recognized that NADPH oxidase is the predominant source of ROS in the vasculature (7). Thus we initially focused our studies on the NADPH oxidase system. NADPH oxidase is a multicomponent system that is composed of cytoplasmic and membrane-bound components that are assembled into an active complex upon stimulation. Therefore, increases in the expression of individual components should correspond to an increase in overall NADPH oxidase activity. Our Western blotting data indicate that the expression of both Rac1 and p47phox was increased in peripheral lung tissue prepared from Shunt compared with Control lambs. This correlates well with our recent in vitro studies in which we showed important roles for Rac1 and p47phox in regulating NADPH oxidase activity in cells isolated from the pulmonary vasculature (23, 30). Interestingly, we did not observe an increase in the expression of the p67phox subunit in peripheral lung tissue prepared from Shunt compared with Control lambs. This is in contrast to our recent studies using the ductal ligation model of PPHN in which we observed an increase in NADPH oxidase activity that was associated with increased expression of the p67phox subunit (6). The differences observed, in which NADPH oxidase subunits are increased during pulmonary hypertension, suggest that there may be different stimuli for the various NADPH oxidase subunits in these two models. It is also possible that some of the increases in superoxide we have observed in Shunt lambs may be due to increased activity of the NADPH oxidase complex independent of increases in Rac1 and p47phox. The pulmonary circulation of the Shunt lambs is exposed to increases in fluid shear, stress, cyclic stretch, and pressure due to the increase in pulmonary blood flow, and both shear stress and mechanical stretch have been previously shown to activate NADPH oxidase in endothelial and smooth muscle cells independently of changes in NADPH oxidase subunit expression. Rather, it is likely that translocation of the subunits from the cytosolic to membrane compartments also plays an important role in NADPH oxidase assembly and activation.

When we utilized pharmacological inhibitors of the NADPH oxidase complex, we found that although these agents could reduce the superoxide generation in the cryosections prepared from Shunt lambs, the levels were not reduced to levels seen in Control lambs. This suggested that there were other sources of superoxide in the Shunt lambs, as suboptimal concentrations of cofactors have been shown to reduce the formation of NO and favor the "uncoupling" of NOS, leading to NOS-mediated reduction of oxygen and formation of superoxide anions. Indeed, recent findings suggest that reductions in BH4 may contribute to the pathogenesis of endothelial dysfunction in hypertension, hypercholesterolemia, diabetes, smoking, and ischemia-reperfusion (4, 14, 16, 27, 37, 41). BH4 is a cofactor essential for the catalytic activity of all three NOS isoforms (13, 19, 25, 40), and studies indicate that cellular BH4 levels have important consequences for the structure of NOS. These include the ability of NOS to shift its heme iron to a high spin state, increase arginine binding, and, at least in some NOS isoforms, stabilize the active dimeric form of the enzyme (13). However, accumulated evidence indicates that an optimal concentration of BH4 is of fundamental importance for normal function of eNOS in vascular endothelial cells. Thus given the importance of BH4 in regulating NO generation from NOS, we next evaluated the levels of BH4 in peripheral lung tissue prepared from Shunt and Control lambs. Our data indicate that there were no significant differences in BH4 levels in Shunt compared with Control lambs. These data are not unexpected as there is little evidence for the loss of BH4 in the dysfunctional blood vessel, although studies have shown that endothelial function can be normalized by BH4 supplementation in experimental animal models of insulin resistance and hypercholesterolemia (21, 36, 37, 41). However, the exact mechanisms responsible for the beneficial effects of BH4 remain unclear. The rate-limiting step in BH4 biosynthesis is controlled by GTP cyclohydrolase I, and alterations in the expression of this enzyme could affect BH4 levels. However, when we evaluated the expression of GTP cyclohydrolase by Western blot analysis, no difference was observed between Control and Shunt lambs, again confirming the BH4 data. However, our analysis of tissue biopterin concentrations does demonstrate that Shunt lambs had significant increases in the levels of BH2, and we also found that exposing purified eNOS to increasing the levels of BH2 led to a significant increase in superoxide generation. These in vivo and in vitro data are in agreement with previous studies that found both peroxynitrite and superoxide could oxidize BH4 (18, 20, 22) and that increases in BH2 relative to BH4 (increased BH2/BH4 ratio) can result in increased superoxide production from eNOS (3, 44).

Increased oxidation of BH4 to BH2 leading to the uncoupling of eNOS and increasing the production of superoxide could also play a role, as both peroxynitrite and superoxide have been shown to oxidize BH4, (18, 20, 22). When BH4 and BH2 were quantified in the lung tissues of Control and Shunt animals, the levels of BH2 were increased in the Shunt animals while BH4 levels were unchanged. This suggests that the GTP cyclohydrolase activity and production of BH4 are not affected by the increased oxidant status but that there is an increased oxidation of BH4 to BH2 in this model. Increases in the level of BH2 have been shown to uncouple eNOS leading to the additional production of superoxide (44), and previously published work has implicated increases in BH2 relative to BH4 (increased BH2/BH4 ratio) with increased superoxide production from eNOS (3, 44). Landmesser et al. (20) has also demonstrated that hypertension led the production of ROS from NADPH oxidase an increase in the oxidation of BH4, uncoupling of eNOS, resulting in a reduction in NO production and increased ROS production from uncoupled eNOS (20). Our previous studies have indicated that, although eNOS expression is increased in Shunt lambs at 4 wk of age, NO-mediated signaling is diminished (5, 34). Thus our data suggest that the infusion of BH4 or its analogs may be beneficial in reducing both the oxidative stress and pulmonary endothelial dysfunction associated with increased pulmonary blood flow. However, further studies will be required to test this hypothesis.

In conclusion this study identifies superoxide as the primary oxidant molecule responsible for the increased oxidative stress in a lamb model of pulmonary hypertension secondary to increased pulmonary blood flow. We conclude that these increases are not due to a reduction in antioxidant scavenging capacity in the lung but, rather, to increased generation from NADPH oxidase and eNOS. Further studies are warranted to test the efficacy of increasing BH4 levels in reducing the endothelial dysfunction and vascular remodeling associated with the development of pulmonary hypertension in this model.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This research was supported in part by National Heart, Lung, and Blood Institute Grants HL-60190 (S. M. Black), HL-67841 (S. M. Black), HL-072123 (S. M. Black), HL-070061 (S. M. Black), and HL-61284 (J. R. Fineman) and American Heart Association, Pacific Mountain Affiliates, Grant 0550133Z (S. M. Black).


   ACKNOWLEDGMENTS
 
The authors thank Cynthia Harmon and Michael Johengen for excellent technical assistance.


   FOOTNOTES
 

Address for reprint requests and other correspondence: S. M. Black, International Heart Inst., Vascular Biology Lab, Rm. 3300, Saint Patrick Hospital, 554 W. Broadway, Missoula, MT 59802 (e-mail: sblack{at}mcg.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Adnot S, Raffestin B, Eddahibi S, Braquet P, and Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 87: 155–162, 1991.[Web of Science][Medline]
  2. Aebi H. Catalase in vitro. Methods Enzymol 105: 121–126, 1984.[Web of Science][Medline]
  3. Alp NJ and Channon K. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24: 1–9, 2003.
  4. Baker TA, Milstien S, and Katusic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 37: 333–338, 2001.[CrossRef][Web of Science][Medline]
  5. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643–H1651, 1998.[Abstract/Free Full Text]
  6. Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, and Black SM. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683–691, 2003.[Abstract/Free Full Text]
  7. Cai H, Griendling KK, and Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471–478, 2003.[CrossRef][Medline]
  8. Cai H and Harrison D. Endothelial dysfunction in cardiovascular disease: the role of oxidant stress. Circ Res 87: 840–844, 2000.[Abstract/Free Full Text]
  9. Celermajer DS, Cullen S, and Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87: 440–446, 1993.[Abstract/Free Full Text]
  10. Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, and Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 99: 9–10, 1990.[Web of Science][Medline]
  11. Elstner EF and Heupel A. Inhibition of nitrite formation from hydroxylammoniumchloride: a simple assay for superoxide dismutase. Anal Biochem 70: 616–620, 1976.[CrossRef][Web of Science][Medline]
  12. Giaid A and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214–221, 1995.[Abstract/Free Full Text]
  13. Gross S, Jones C, Hattori Y, and Raman C. Tetrahydrobiopterin: an essential cofactor of nitric oxide synthase with an elusive role. In: Nitric Oxide Biology and Pathobiology. San Diego, CA: Academic, 2000, p. 167–187.
  14. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, and Munzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86: E36–E41, 2000.[Web of Science][Medline]
  15. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20: 443–448, 1996.[CrossRef][Web of Science][Medline]
  16. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 281: H981–H986, 2001.[Abstract/Free Full Text]
  17. Khan JY and Black SM. Developmental changes in murine brain antioxidant enzymes. Pediatr Res 54: 77–82, 2003.[CrossRef][Web of Science][Medline]
  18. Kuzkaya N, Weissmann N, Harrison DG, and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546–22554, 2003.[Abstract/Free Full Text]
  19. Kwon NS, Nathan CF, and Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 264: 20496–20501, 1989.[Abstract/Free Full Text]
  20. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201–1209, 2003.[CrossRef][Web of Science][Medline]
  21. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, and Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588–593, 1997.[Abstract/Free Full Text]
  22. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282–1288, 2001.[Abstract/Free Full Text]
  23. Mata-Greenwood E, Grobe A, Kumar S, Noskina Y, and Black SM. Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-beta1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am J Physiol Lung Cell Mol Physiol 289: L288–L299, 2005.[Abstract/Free Full Text]
  24. Matsubara T and Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 137: 3295–3298, 1986.[Abstract]
  25. Mayer B and Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 22: 477–481, 1997.[CrossRef][Web of Science][Medline]
  26. Meyrick B, Gamble W, and Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol Heart Circ Physiol 239: H692–H702, 1980.[Abstract/Free Full Text]
  27. Milstien S and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681–684, 1999.[CrossRef][Web of Science][Medline]
  28. Milstien S, Kaufman S, and Summer GK. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by measurement of oxidized and reduced pterins in urine. Pediatrics 65: 806–810, 1980.[Abstract/Free Full Text]
  29. Motulsky H. Intuitive Biostatistics. New York: Oxford University Press, 1995.
  30. Patil S, Bunderson M, Wilham J, and Black SM. Important role for Rac1 in regulating reactive oxygen species generation and pulmonary arterial smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 287: L1314–L1322, 2004.[Abstract/Free Full Text]
  31. Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG, Trusler GA, Rowe RD, Olley PM, and Cutz E. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 55: 632–653, 1986.[Web of Science][Medline]
  32. Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, and Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 69: 655–667, 1984.[Abstract/Free Full Text]
  33. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, and Fineman JR. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606–613, 1995.[Abstract/Free Full Text]
  34. Reddy VM, Wong J, Liddicoat JR, Johengen M, Chang R, and Fineman JR. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 271: H562–H570, 1996.[Abstract/Free Full Text]
  35. Reiter CD, Teng RJ, and Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 275: 32460–32466, 2000.[Abstract/Free Full Text]
  36. Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, and Kikkawa R. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2– imbalance in insulin-resistant rat aorta. Diabetes 48: 2437–2445, 1999.[Abstract]
  37. Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, and Kashiwagi A. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ Res 87: 566–573, 2000.[Abstract/Free Full Text]
  38. Steinhorn R, Russell J, Lakshminrusimha S, Gugino S, Black S, and Fineman J. Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 280: H311–H317, 2001.[Abstract/Free Full Text]
  39. Taniyama Y and Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075–1081, 2003.[Abstract/Free Full Text]
  40. Tayeh MA and Marletta MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem 264: 19654–19658, 1989.[Abstract/Free Full Text]
  41. Tiefenbacher CP, Bleeke T, Vahl C, Amann K, Vogt A, and Kubler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102: 2172–2179, 2000.[Abstract/Free Full Text]
  42. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248–252, 2004.[Abstract/Free Full Text]
  43. Touyz RM and Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122: 339–352, 2004.[CrossRef][Web of Science][Medline]
  44. Vasquez-Vivar J, Martasek P, Whitsett J, Joseph J, and Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 362: 733–739, 2002.[CrossRef][Web of Science][Medline]
  45. Wassmann S, Wassmann K, and Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44: 381–386, 2004.[Abstract/Free Full Text]
  46. Wedgwood S and Black SM. Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 5: 759–769, 2003.[CrossRef][Web of Science][Medline]
  47. Wedgwood S, Steinhorn RH, Bunderson M, Wilham J, Lakshminrusimha S, Brennan LA, and Black SM. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 289: L660–L666, 2005.[Abstract/Free Full Text]
  48. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, and Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84: 2280–2285, 1991.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. P. Weerackody, D. J. Welsh, R. M. Wadsworth, and A. J. Peacock
Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1312 - H1320.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. N. Farrow, S. Lakshminrusimha, W. J. Reda, S. Wedgwood, L. Czech, S. F. Gugino, J. M. Davis, J. A. Russell, and R. H. Steinhorn
Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L979 - L987.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Oishi, D. A. Wiseman, S. Sharma, S. Kumar, Y. Hou, S. A. Datar, A. Azakie, M. J. Johengen, C. Harmon, S. Fratz, et al.
Progressive dysfunction of nitric oxide synthase in a lamb model of chronically increased pulmonary blood flow: a role for oxidative stress
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L756 - L766.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nozik-Grayck, H. B. Suliman, S. Majka, J. Albietz, Z. Van Rheen, K. Roush, and K. R. Stenmark
Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L422 - L430.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
V. G. DeMarco, J. Habibi, A. T. Whaley-Connell, R. I. Schneider, R. L. Heller, J. P. Bosanquet, M. R. Hayden, K. Delcour, S. A. Cooper, B. T. Andresen, et al.
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2659 - H2668.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. Terrier, M. C. Tamby, L. Camoin, P. Guilpain, C. Broussard, G. Bussone, A. Yaici, F. Hotellier, G. Simonneau, L. Guillevin, et al.
Identification of Target Antigens of Antifibroblast Antibodies in Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1128 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. P. Jankov, C. Kantores, J. Pan, and J. Belik
Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L233 - L245.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Kamezaki, H. Tasaki, K. Yamashita, M. Tsutsui, S. Koide, S. Nakata, A. Tanimoto, M. Okazaki, Y. Sasaguri, T. Adachi, et al.
Gene Transfer of Extracellular Superoxide Dismutase Ameliorates Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 219 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. M. Black, J. M. DeVol, and S. Wedgwood
Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C345 - C354.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. R. Morris, J. H. Suh, W. Hagar, S. Larkin, D. A. Bland, M. H. Steinberg, E. P. Vichinsky, M. Shigenaga, B. Ames, F. A. Kuypers, et al.
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease
Blood, January 1, 2008; 111(1): 402 - 410.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Sud, S. Sharma, D. A. Wiseman, C. Harmon, S. Kumar, R. C. Venema, J. R. Fineman, and S. M. Black
Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1444 - L1453.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Sharma, A. C. Grobe, D. A. Wiseman, S. Kumar, M. Englaish, I. Najwer, E. Benavidez, P. Oishi, A. Azakie, J. R. Fineman, et al.
Lung antioxidant enzymes are regulated by development and increased pulmonary blood flow
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L960 - L971.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Wu, O. Platoshyn, A. L. Firth, and J. X.-J. Yuan
Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L952 - L959.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Lakshminrusimha, D. Wiseman, S. M. Black, J. A. Russell, S. F. Gugino, P. Oishi, R. H. Steinhorn, and J. R. Fineman
The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1491 - H1497.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grobe, A. C.
Right arrow Articles by Black, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grobe, A. C.
Right arrow Articles by Black, S. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.